Mumbai
₹ 13,380 /gm
Indian billionaire Pankaj R. Patel, born on 16 March 1953, emerged as a pivotal force in India's pharmaceutical landscape, helming Zydus Lifesciences, India’s fifth-largest pharma company. A Gujarat University alumnus, Patel's strategic leadership transformed Zydus from a precarious financial standing into a global innovation hub, developing breakthrough therapies like the diabetic medication Lipaglyn and the H1N1 vaccine VaxiFlu-s. With esteemed positions in national scientific and economic boards, Patel's accolades include "Best Pharma Man of the year 2003" and a ranking in the prominent Pharma 40 list, mirroring his influence in healthcare innovation.
March 19, 1953
73 years
Pharmaceuticals
Healthcare
India
Ahmedabad
Bachelor of Arts/Science, Gujarat University; Master of Science, Gujarat University
Pankaj Ramanbhai Patel, an Indian billionaire businessman and chairman of Zydus Lifesciences, was born on 16 March 1953. He belongs to the Gujarati community. During his student days, he was a leader of the Rashtriya Vidhyarthi Parishad and an active leader of the Navmiraman Movement. Patel holds a Bachelor of Pharmacy and Master of Pharmacy degrees from L.M. College of Pharmacy, Gujarat University, as well as a Bachelor of Arts in Science and Law from the University of Mumbai.
Pankaj Patel: Family
Pankaj Patel is married to Priti Patel, daughter of Dr. B D Patel. They have two children: Dr. Sharvil Patel, who is the managing director of Cadila Healthcare Ltd., and Shivani, who is married to Pranav D Patel.
Pankaj Patel: Career Highlights
Patel joined Cadila Healthcare in 1976 after completing his education. In 1995, Cadila Laboratories and Cadila Healthcare split under the Zydus Group. After a formal separation between the two founding families, Patel took charge of Zydus Lifesciences and Cadila Healthcare in the same year. Despite facing challenges, such as a Rs 200-crore company with overheads of Rs 400 crore, Patel led the company to significant growth.
One of Patel's notable achievements was the development of the first Indian drug for high-cholesterol diabetics called Lipaglyn in 2013. He also created the Sugar Free brand and Everyuth face wash. Patel played a crucial role in combating swine flu by launching VaxiFlu-s, the first Indian H1N1 vaccine.
Under Patel's leadership, Zydus Lifesciences grew to become the fifth largest drugmaker in India with operations in 70 countries worldwide. He formed an alliance with German biotech firm Pieris Pharmaceuticals to develop and market a new class of protein therapeutics. Patel was also the first to file to sell a generic version of Shire PLC's ulcer drug, Lialda, in the United States.
In addition to his role at Zydus Lifesciences, Patel is the chairman of Zydus Hospitals, a large chain of hospitals in Gujarat.
During the Covid-19 pandemic, he ramped up production to become one of the largest suppliers of hydroxychloroquine and developed a variant of Remdesivir. Patel is also involved in the development of a vaccine called Zycov-D to fight Covid.
Pankaj Patel: Companies
Pankaj Patel is associated with the following companies:
Pankaj Patel: Major Achievements
Some of Pankaj Patel's major achievements include:
Pankaj Patel: Awards & Achievements
Pankaj Patel has received numerous awards and recognitions for his contributions to the pharmaceutical industry and society. Some of his notable awards include:
Pankaj Patel: Personal Life & Legacy
Pankaj Patel enjoys traveling, especially near rivers or mountains, and is interested in theatre. He is known for his philanthropic work and believes in non-monetary aspects of philanthropy like giving time, ideas, and volunteering. In August 2012, Patel purchased a Challenger-604 jet with Dinesh Patel.
Pankaj Patel: Trivia
Pankaj Patel is a well-known philanthropist in India and believes in the non-monetary aspects of philanthropy, such as giving time, ideas, and volunteering. He is also a member of several prestigious societies and organizations, including the Indian Pharmaceutical Alliance, Indian Drug Manufacturers Association, Basic Chemicals, Pharmaceuticals and Cosmetics Export Promotion Council, and Gujarat Chambers of Commerce and Industry.
Pankaj Ramanbhai Patel is born.
Pankaj Ramanbhai Patel joins Cadila Healthcare after graduation.
Cadila Laboratories and Cadila Healthcare split under Zydus Group.
Pankaj Ramanbhai Patel takes charge of Zydus Lifesciences after a formal separation between the two founding families from Zydus Cadila to Zydus Lifesciences and Cadila Healthcare.
Pankaj Ramanbhai Patel is awarded the "Best Pharma Man of the year" by the Foundation of Indian Industry and Economists.
Pankaj Ramanbhai Patel purchases a Challenger-604 jet with Dinesh Patel.
Zydus Lifesciences develops the first Indian drug for high-cholesterol diabetics (Lipaglyn).
Pankaj Ramanbhai Patel serves as President of FICCI.
Pankaj Ramanbhai Patel is ranked in the First Pharma 40 list of 'world's most influential people in the field of healthcare' by World Pharmaceutical Frontiers.
Zydus Lifesciences ramps up production during the Covid-19 pandemic to become one of the largest suppliers of hydroxychloroquine and develops a variant of Remdesivir.
What is Pankaj Patel's current net worth?
What is Pankaj Patel's current global rank among billionaires?
What is Pankaj Patel's current ranking within the India?
What was the change in Pankaj Patel's net worth compared to the previous year?
What are Pankaj Patel's main sources of wealth?
In which industry does Pankaj Patel primarily operate?
What is Pankaj Patel educational background?
How old is Pankaj Patel?
How many children does Pankaj Patel have?
Who is Pankaj Ramanbhai Patel and what is his role in Zydus Lifesciences?
What challenges did Pankaj Patel face when taking charge of Zydus Lifesciences and how did he overcome them?
What leadership roles has Pankaj Patel fulfilled and how has he contributed to the field of education and healthcare?
What honors has Pankaj Ramanbhai Patel received for his contributions to the pharmaceutical industry?
Can you describe Pankaj Patel's personal interests and philanthropic activities?